TABLE 3.
Short‐term and 3‐month outcomes of the whole cohort, and non‐COVID+ and COVID+ ischemic stroke patients
| Outcomes | Total (N = 2338) | Non‐COVID+ (n = 2305) | COVID+ (n = 33) | P value |
|---|---|---|---|---|
| Short‐term outcomes | ||||
| NIHSS at 24 h | 2 (0–6) | 2 (0–6) | 4 (1.9–9.4) | 0.025 |
| sICH | 34 (1.5%) | 33 (1.4%) | 1 (3%) | 0.978 |
| In‐hospital stroke recurrence | 46 (2%) | 45 (2%) | 1 (3%) | 1.000 |
| In‐hospital mortality | 133 (5.7%) | 129 (5.6%) | 4 (12.1%) | 0.221 |
| Discharge destination | ||||
| Home | 940 (42.8%) | 937 (43.2%) | 3 (10.7%) | 0.005 |
| Other acute care hospital | 304 (13.8%) | 297 (13.7%) | 7 (25%) | |
| Rehabilitation hospital | 843 (38.4%) | 828 (38.2%) | 15 (53.6%) | |
| Nursing home, palliative care center, or other medical facility | 108 (4.9%) | 105 (4.8%) | 3 (10.7%) | |
| 3‐month outcomes a | ||||
| mRS, median (IQR) | 2 (0–3) | 2 (0–3) | 3 (2–5.3) | 0.003 b |
| Stroke recurrence | 52 (2.8%) | 51 (2.7%) | 1 (4%) | 1.000 |
| ICH | 8 (0.4%) | 8 (0.4%) | 0 (0%) | 1.000 |
| Death | 271 (13.2%) | 264 (13.1%) | 7 (24.1%) | 0.088 c |
Abbreviations: ICH, intracranial hemorrhage; IQR, interquartile range; mRS, modified Rankin Scale; NIHSS, National Institutes of Health Stroke Scale; sICH, symptomatic intracranial hemorrhage.
a
Calculated for patients with available 3‐month outcomes, COVID+: n = 29, non‐COVID+: n = 2019.
b
P value of unadjusted ordinal regression analysis for higher mRS shift (cOR 2.57, 95% CI 1.37–4.81).
c
P value of unadjusted logistic regression analysis for mortality (OR 1.46, 95% CI 0.61–3.50).